Nxera Pharma Co (FRA:JSS) Short-Term Capital Lease Obligation : €5.5 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Nxera Pharma Co Short-Term Capital Lease Obligation?

Nxera Pharma Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €5.5 Mil.

Nxera Pharma Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (€5.4 Mil) to Dec. 2024 (€5.5 Mil) but then declined from Dec. 2024 (€5.5 Mil) to Mar. 2025 (€5.5 Mil).

Nxera Pharma Co's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (€1.2 Mil) to Dec. 2023 (€5.3 Mil) and increased from Dec. 2023 (€5.3 Mil) to Dec. 2024 (€5.5 Mil).

Nxera Pharma Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Nxera Pharma Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Short-Term Capital Lease Obligation Chart

Nxera Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.35

1.50

1.23

5.30

5.54

Nxera Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															5.20	5.07	5.41	5.54	5.49

Nxera Pharma Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Nxera Pharma Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

4565:Japan

Address

Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website

https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines